SOX2 and breast cancer: Indeed, SOX2 is frequently gained in BRCA1 germline mutated tumors and is preferentially expressed in sporadic basal-like phenotypes having similar phenotypic and clinical characteristics to breast cancer arising in BRCA1 mutation carriers.